Exudative Macular Degeneration

9 clinical trials · Condition

Record	Firm	Date
Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting (NCT05093374)	Medical University of Vienna	2021-03-01
MMP-9 Inhibition for Recalcitrant Wet AMD (NCT04504123)	University of Iowa	2020-11-04
CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl) (NCT03803631)	Centre Hospitalier Intercommunal Creteil	2018-04-04
Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD (NCT01835067)	King's College Hospital NHS Trust	2014-09-01
Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment (NCT02287298)	The Retina Center of St. Louis County, PC	2014-08-01
Pilot Study of X-82 in Patients With Wet AMD (NCT01674569)	Tyrogenex	2012-10-01
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept (NCT01617148)	Rishi Singh	2012-06-01
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD) (NCT01535950)	Novartis Pharmaceuticals	2012-02-01
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration (NCT01473251)	Vitreo-Retinal Associates, Michigan	2011-11-01

Every clearance here is in the API, with alerts when new ones post.